Weight gain and increased central obesity in the early phase of Parkinson's disease

Clinical Nutrition

Volumn 33, Issue 6, 2014, Pages 1132-1139

  Vikdahl, Magdalena ^a   Carlsson, Maine ^b   Linder, Jan ^a   Forsgren, Lars ^a   Håglin, Lena ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Anthropometry; Body composition; Body weight; Nutrition; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; ANTHROPOMETRY; ARTICLE; BIOELECTRICAL IMPEDANCE SPECTROSCOPY; BODY COMPOSITION; BODY WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DYSPHAGIA; FAT MASS; FEMALE; FOLLOW UP; HOEHN AND YAHR SCALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OBESITY; PARKINSON DISEASE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SKINFOLD; SPECTROSCOPY; UNIFIED PARKINSON DISEASE RATING SCALE; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO; WEIGHT CHANGE; WEIGHT GAIN; ABDOMINAL OBESITY; COMPLICATION; IMPEDANCE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; STATISTICAL MODEL;

AGED; ANTHROPOMETRY; BODY COMPOSITION; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ELECTRIC IMPEDANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; NUTRITION ASSESSMENT; OBESITY, ABDOMINAL; PARKINSON DISEASE; PROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 84920172427     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.12.012     Document Type: Article

References (30)

1. van der Marck M.A., Dicke H.C., Uc E.Y., Kentin Z.H., Borm G.F., Bloem B.R., et al. Body mass index in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 2012, 18:263-267.
2. Chen H., Zhang S.M., Hernan M.A., Willett W.C., Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 2003, 53:676-679.
3. Levi S., Cox M., Lugon M., Hodkinson M., Tomkins A. Increased energy expenditure in Parkinson's disease. BMJ 1990, 301:1256-1257.
4. Toth M.J., Fishman P., Phoehlman E.T. Free-living daily energy expenditure in patients with Parkinson's disease. Neurology 1997, 48:88-91.
5. Barichella M., Cereda E., Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009, 24:1881-1892.
6. Beyer P.L., Palarino M.Y., Michalek D., Busenbark K., Koller W.C. Weight change and body composition in patients with Parkinson's disease. JAm Diet Assoc 1995, 95:979-983.
7. Lorefält B., Toss G., Granérus A.K. Weight loss, body fat mass, and leptin in Parkinson's disease. Mov Disord 2009, 24:885-890.
8. Petroni M.L., Albani G., Bicchiega V., Baudo S., Vinci C., Montesano A., et al. Body composition in advanced-stage Parkinson's disease. Acta Diabetol 2003, 40(Suppl.1):187-190.
9. Kuranuki S., Arai C., Terada S., Nakamura T. Possible regulatory factors for intra-abdominal fat mass in a rat model of Parkinson's disease. Nutrition 2011, 27:239-245.
10. Sheard J.M., Ash S., Silburn P.A., Kerr G.K. Prevalence of malnutrition in Parkinson's disease: a systematic review. Nutr Rev 2011, 69:520-532.
11. Cushing M.L., Traviss K.A., Calne S.M. Parkinson's disease: implications for nutritional care. Can J Diet Pract Res 2002, 63:81-87.
12. Miller N., Allcock L., Hildreth A.J., Jones D., Noble E., Burn D.J. Swallowing problems in Parkinson disease: frequency and clinical correlates. JNeurol Neurosurg Psychiatry 2009, 80:1047-1049.
13. Ådén E., Carlsson M., Poortvliet E., Stenlund H., Linder J., Edström M., et al. Dietary intake and olfactory function in patients with newly diagnosed Parkinson's disease: a case-control study. Nutr Neurosci 2011, 14:25-31.
14. Barichella M., Cereda E., Madio C., Iorio L., Pusani C., Cancello R., et al. Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis. Br J Nutr 2013, 110:347-353.
15. Linder J., Stenlund H., Forsgren L. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 2010, 25:341-348.
16. Gibb W.R., Lees A.J. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. JNeurol Neurosurg Psychiatry 1988, 51:745-752.
17. Fahn S., Elton R.L., the UPDRS Development Committee Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-164. Macmillan Healthcare Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D. Calne, M. Goldstein (Eds.).
18. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
19. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. JPsychiatr Res 1975, 12:189-198.
20. Tomlinson C.L., Stowe R., patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2685.
21. Durnin J.V., Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974, 32:77-97.
22. Håglin L., Hagman U., Nilsson M. Evaluation of the meal model "Matmallen". A means of estimating consumed amounts of food. Scand J Nutr 1995, 39:79-83.
23. Durnin J.V.G.A., Passmore R. Energy, work and leisure 1967, Heinemann Educational Books, Ltd, London.
24. FAO/WHO/UNU Energy an protein requirements report of a joint FAO/WHO/UNU wxpert consultation 1985, World Health Organization, Geneva, Technical Report Series 724.
25. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., et al. Variable expression of Parkinson's disease - a baseline analysis of the DATATOP cohort. Neurology 1999, 40:1529-1534.
26. Cereda E., Cassani E., Barichella M., Spadafranca A., Caccialanza R., Bertoli S., et al. Low cardiometabolic risk in Parkinson's disease is independent of nutritional status, body composition and fat distribution. Clin Nutr 2012, 31:699-704.
27. Cereda E., Sansone V., Meola G., Malavazos A.E. Increased visceral adipose tissue rather than BMI as a risk factor for dementia. Age Ageing 2007, 36:488-491.
28. Isaac V., Sim S., Zheng H., Zagorodnov V., Tai E.S., Chee M. Adverse associations between visceral adiposity, brain structure, and cognitive performance in healthy elderly. Front Aging Neurosci 2011, 3:12.
29. Prado C.M., Wells J.C., Smith S.R., Stephan B.C., Siervo M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin Nutr 2012, 31:583-601.
30. Nirenberg M.J., Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006, 21:524-529.